| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/04/1997 | EP0776218A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 06/04/1997 | EP0664707B1 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma |
| 06/04/1997 | CN1151157A Metalloproteinase inhibitors |
| 06/04/1997 | CN1151120A Method and compositions useful for inhibition of angiogenesis |
| 06/03/1997 | US5635504 Diazepine containing dual action inhibitors |
| 06/03/1997 | US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| 05/29/1997 | WO1997019074A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 05/29/1997 | WO1997018835A1 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 05/29/1997 | WO1997018813A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | WO1997018812A1 Combination therapy for treating glaucoma |
| 05/29/1997 | CA2238081A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | CA2237898A1 Combination therapy for treating glaucoma |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0774962A1 Use of dha as a pharmaceutical composition |
| 05/28/1997 | EP0717620A4 Substituted 2-aminotetralins |
| 05/27/1997 | US5633275 Photochemotherapeutical obstruction of newly-formed blood vessels |
| 05/27/1997 | US5633232 Tachykinin antagonist dipeptides |
| 05/27/1997 | US5633227 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/22/1997 | WO1997018223A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | WO1997017990A1 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 05/22/1997 | WO1997017989A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 05/22/1997 | WO1997017983A1 Methods of treating disorders of non-visual sensory epithelia |
| 05/22/1997 | WO1997017969A1 Dihydropyrimidines and uses thereof |
| 05/22/1997 | CA2237774A1 Dihydropyrimidines and uses thereof |
| 05/22/1997 | CA2237565A1 Improved method and agents for inhibiting protein aging |
| 05/21/1997 | EP0774254A1 Pharmaceutical composition for preventing or treating dry eye or disease caused thereby comprising 12-sulfodehydroabietic acid |
| 05/21/1997 | EP0774251A2 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 05/21/1997 | EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases |
| 05/21/1997 | EP0580738B1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| 05/21/1997 | CN1034939C Process for preparing indolone and indoldione derivatives with cholinergic activity |
| 05/20/1997 | US5631287 Storage-stable prostaglandin compositions |
| 05/20/1997 | US5631267 Method for the treatment of eosinophil-associated diseases by administration of topical anesthetics |
| 05/20/1997 | US5631243 Protective lubricants for eye surgery which can easily be removed, in mixture with mucopolysaccharides |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997017316A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| 05/15/1997 | WO1997017085A2 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 05/15/1997 | WO1997017077A1 Topical composition containing capsazepine |
| 05/15/1997 | WO1997017067A1 Sublingual and buccal administration of selegiline |
| 05/15/1997 | CA2234797A1 Topical composition containing capsazepine |
| 05/14/1997 | EP0773024A2 Use of N-substituted nicotinamide compounds for the treatment of acute and chronic inflammatory diseases |
| 05/14/1997 | EP0773022A2 Pharmaceutical composition for the treatment of rhinitus, containing sympathomometic and pantothenol and/or pantothenic acid |
| 05/14/1997 | EP0772629A1 T cell epitopes of rye grass pollen allergen |
| 05/14/1997 | EP0772610A1 Dihydrobenzofuranes |
| 05/14/1997 | EP0772596A1 INDOLIZINE sPLA2 INHIBITORS |
| 05/14/1997 | EP0772594A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 05/14/1997 | EP0772592A1 1H-INDOLE-1-FUNCTIONAL sPLA 2? INHIBITORS |
| 05/14/1997 | CN1149472A Nutritive preparation for computer operator and its production technology |
| 05/14/1997 | CN1149454A Method for curing tinnitus by nerve protecting agent |
| 05/14/1997 | CN1034869C Peptide compound and its preparing method for pharmaceutical salt |
| 05/13/1997 | US5629337 Methods for treating asthma using optically pure (-)-zileuton |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629312 Reducing neuron damage caused by gp-120 protein in aids patients |
| 05/09/1997 | WO1997016729A1 Combinatorial dihydrobenzopyran library |
| 05/09/1997 | WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | WO1997016197A1 Extracts of shark cartilage |
| 05/09/1997 | WO1997016179A1 Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 05/09/1997 | WO1997016175A1 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 05/09/1997 | CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/07/1997 | EP0771563A2 Use of 5-HTiA receptor ligands for the treatment of glaucoma |
| 05/07/1997 | EP0771216A1 Methods and compositions for the specific coagulation of vasculature |
| 05/07/1997 | EP0771198A1 Dihydro-2,3-benzodiazepine derivatives |
| 05/07/1997 | EP0771195A1 Method of inhibiting nitric oxide formation |
| 05/07/1997 | CN1149319A Angiostatin and method of use for inhibition of Angiogenesis |
| 05/07/1997 | CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds |
| 05/06/1997 | US5627208 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 05/06/1997 | US5627195 Tetrandrine |
| 05/06/1997 | US5627182 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 05/06/1997 | US5626865 Enzyme-orthokeratology |
| 05/02/1997 | EP0770395A1 Use of botulinum toxins for treating headache |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770390A1 Nasally administrable compositions containing physiologically active peptides |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769940A1 INDENE sPLA 2? INHIBITORS |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015330A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | WO1997015307A1 Eye drops |
| 05/01/1997 | CA2235685A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | CA2235614A1 Eye drops |
| 04/30/1997 | CN1148810A Medicinal composition for treating glaucoma |
| 04/30/1997 | CN1148809A Ocular tension depressant |
| 04/30/1997 | CN1148503A Application of noval peptidic compound in preparation of medicine |
| 04/29/1997 | US5624957 Retinoid active compounds |
| 04/29/1997 | US5624945 Use of riluzole for the treatment of neuro-aids |
| 04/29/1997 | US5624941 Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 04/29/1997 | US5624939 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 04/29/1997 | CA2089207C Amphoteric tricyclic compound |
| 04/29/1997 | CA2003190C Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid |
| 04/28/1997 | CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases |
| 04/23/1997 | EP0769056A1 NON-SPLICING VARIANTS OF gp350/220 |
| 04/23/1997 | EP0768819A1 Combined virustatic antimediator (covam) treatment of common colds |
| 04/23/1997 | CN1148389A Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 04/22/1997 | US5622992 Administering topical aromatic releasing decongestant composition to treat nasal symptoms |
| 04/22/1997 | US5622976 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 04/22/1997 | CA2015235C Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013785A1 Transferrin receptor protein of moraxella |
| 04/17/1997 | WO1997013751A1 Indole carbamates as leukotriene antagonists |
| 04/17/1997 | WO1997013744A1 3-amino-propoxyphenyl derivatives (i) |